Balchem Corporation
BCPC
$154.05
$0.000.00%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.01B | 985.93M | 964.54M | 953.68M | 942.38M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.01B | 985.93M | 964.54M | 953.68M | 942.38M |
| Cost of Revenue | 650.48M | 632.95M | 621.68M | 617.48M | 617.52M |
| Gross Profit | 363.07M | 352.98M | 342.86M | 336.21M | 324.86M |
| SG&A Expenses | 139.54M | 135.68M | 131.65M | 134.95M | 143.96M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 807.98M | 786.43M | 770.69M | 769.22M | 777.70M |
| Operating Income | 205.57M | 199.50M | 193.86M | 184.47M | 164.68M |
| Income Before Tax | 193.48M | 185.33M | 177.54M | 166.45M | 155.24M |
| Income Tax Expenses | 44.28M | 42.58M | 41.00M | 37.98M | 33.70M |
| Earnings from Continuing Operations | 149.20 | 142.75 | 136.54 | 128.48 | 121.54 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 149.20M | 142.75M | 136.54M | 128.48M | 121.54M |
| EBIT | 205.57M | 199.50M | 193.86M | 184.47M | 164.68M |
| EBITDA | 250.36M | 243.72M | 239.10M | 232.37M | 215.74M |
| EPS Basic | 4.61 | 4.40 | 4.21 | 3.97 | 3.76 |
| Normalized Basic EPS | 3.75 | 3.60 | 3.45 | 3.24 | 2.82 |
| EPS Diluted | 4.57 | 4.36 | 4.17 | 3.93 | 3.72 |
| Normalized Diluted EPS | 3.72 | 3.57 | 3.42 | 3.22 | 2.80 |
| Average Basic Shares Outstanding | 129.61M | 129.72M | 129.67M | 129.48M | 129.41M |
| Average Diluted Shares Outstanding | 130.63M | 130.82M | 130.79M | 130.61M | 130.54M |
| Dividend Per Share | 0.87 | 0.87 | 0.87 | 0.87 | 0.79 |
| Payout Ratio | 18.95% | 19.81% | 20.71% | 19.91% | 21.04% |